Mannatech, Incorporated (NASDAQ: MTEX), a leading developer and provider of dietary supplements and skin care solutions, today announced a number of compliance initiatives related to sales and marketing activities utilized by the Company's independent sales associates. "On behalf of Mannatech's Board of Directors and executive management team, we are announcing that significant steps have been taken to address a wide range of issues which have been under review," said Stan Fredrick, lead director of the Company's Board of Directors. "Our management team will continue reviewing Company policies and procedures for ongoing improvements and industry best practices." The following list outlines these initiatives:

1. Associates should immediately cease the use of all materials in any form, including educational materials, that link the benefits of glyconutrients in association with any particular disease, disease process, or disease claim in conjunction with the sale of Mannatech products.

View the Mannatech review